99 related articles for article (PubMed ID: 11317533)
21. [Prognostic models for Hodgkin's disease].
Panyshin GA; Datsenko PV; Sotnikov VM; Mel'nik IuD
Vopr Onkol; 2006; 52(5):538-43. PubMed ID: 17168362
[TBL] [Abstract][Full Text] [Related]
22. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
23. Detection and prognostic value of cytokeratin positive tumor cells in bone marrow of patients with renal cell carcinoma.
Buchner A; Riesenberg R; Kotter I; Crispin A; Hofstetter A; Oberneder R
J Urol; 2003 Nov; 170(5):1747-51. PubMed ID: 14532768
[TBL] [Abstract][Full Text] [Related]
24. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors.
Brown JE; Cook RJ; Major P; Lipton A; Saad F; Smith M; Lee KA; Zheng M; Hei YJ; Coleman RE
J Natl Cancer Inst; 2005 Jan; 97(1):59-69. PubMed ID: 15632381
[TBL] [Abstract][Full Text] [Related]
25. [Histological features of the bone marrow in Hodgkin's disease].
Polonskaia NIu; Shishkin IP
Probl Gematol Pereliv Krovi; 1979 Dec; 24(12):20-4. PubMed ID: 523447
[No Abstract] [Full Text] [Related]
26. The changing trends of adult Hodgkin's disease in Saudi Arabia.
Al-Diab AI; Siddiqui N; Sogiawalla FF; Fawzy EM
Saudi Med J; 2003 Jun; 24(6):617-22. PubMed ID: 12847590
[TBL] [Abstract][Full Text] [Related]
27. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.
Kaifi JT; Yekebas EF; Schurr P; Obonyo D; Wachowiak R; Busch P; Heinecke A; Pantel K; Izbicki JR
J Natl Cancer Inst; 2005 Dec; 97(24):1840-7. PubMed ID: 16368946
[TBL] [Abstract][Full Text] [Related]
28. Clinical outcome of gastric cancer patients with bone marrow metastases.
Kim HS; Yi SY; Jun HJ; Lee J; Park JO; Park YS; Jang J; Kim HJ; Ko Y; Lim HY; Kang WK
Oncology; 2007; 73(3-4):192-7. PubMed ID: 18418012
[TBL] [Abstract][Full Text] [Related]
29. Spleen involvement in Hodgkin's lymphoma: assessment and risk profile.
Rueffer U; Sieber M; Stemberg M; Gossmann A; Josting A; Koch T; Grotenhermen F; Diehl V;
Ann Hematol; 2003 Jul; 82(7):390-6. PubMed ID: 12764547
[TBL] [Abstract][Full Text] [Related]
30. [Advances of bone marrow biopsy pathology in diagnosing lymphoma bone marrow involvement].
Liu EB; Chen HS
Ai Zheng; 2005 Nov; 24(11):1416-20. PubMed ID: 16552975
[TBL] [Abstract][Full Text] [Related]
31. Hodgkin's disease in the bone marrow.
Weiss RB; Brunning RD; Kennedy BJ
Cancer; 1975 Dec; 36(6):2077-83. PubMed ID: 1203865
[TBL] [Abstract][Full Text] [Related]
32. [Granulocyte turnover in advanced Hodgkin's disease].
Prazmowska-Owczarek B; Hansz J
Z Gesamte Inn Med; 1981 Sep; 36(18):678-80. PubMed ID: 7314751
[TBL] [Abstract][Full Text] [Related]
33. The bone marrow in Hodgkin's disease--a two year study.
Ananthamurthy A; Kurien A; Ramnarayan K
Indian J Cancer; 2000 Dec; 37(4):173-83. PubMed ID: 12018570
[TBL] [Abstract][Full Text] [Related]
34. Bone marrow micrometastases and markers of angiogenesis in esophageal cancer.
Spence GM; Graham AN; Mulholland K; Maxwell P; McCluggage WG; Sloan JM; McGuigan JA
Ann Thorac Surg; 2004 Dec; 78(6):1944-9; discussion 1950. PubMed ID: 15561005
[TBL] [Abstract][Full Text] [Related]
35. Immunocytochemical detection of occult tumor cells in the bone marrow: prognostic impact on early stages of lung cancer.
Nosotti M; Tosi D; Palleschi A; Rosso L; Mendogni P; Santambrogio L
Eur Surg Res; 2008; 41(3):267-71. PubMed ID: 18594145
[TBL] [Abstract][Full Text] [Related]
36. [Relevance of certain factors in the effectiveness of chemoradiotherapy for Hodgkin's disease].
Kanaev SV; Gershanovich ML; Pozharisskiĭ KM; Girshovich MM; Golovanov SG
Vopr Onkol; 2005; 51(1):56-9. PubMed ID: 15909808
[TBL] [Abstract][Full Text] [Related]
37. Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis.
Visco C; Nadali G; Vassilakopoulos TP; Bonfante V; Viviani S; Gianni AM; Federico M; Luminari S; Peethambaram P; Witzig TE; Pangalis G; Cabanillas F; Medeiros LJ; Sarris AH; Pizzolo G
Eur J Haematol; 2006 Nov; 77(5):387-94. PubMed ID: 16879607
[TBL] [Abstract][Full Text] [Related]
38. Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.
Noordijk EM; Carde P; Dupouy N; Hagenbeek A; Krol AD; Kluin-Nelemans JC; Tirelli U; Monconduit M; Thomas J; Eghbali H; Aleman BM; Bosq J; Vovk M; Verschueren TA; Pény AM; Girinsky T; Raemaekers JM; Henry-Amar M
J Clin Oncol; 2006 Jul; 24(19):3128-35. PubMed ID: 16754934
[TBL] [Abstract][Full Text] [Related]
39. Prospective study of combined modality treatment or radiotherapy alone in the management of early-stage adult Hodgkin's disease.
Yildiz F; Zengin N; Engin H; Güllü I; Barista I; Caglar M; Ozyar E; Cengiz M; Gürkaynak M; Zorlu F; Caner B; Atahan IL; Tekuzman G
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):839-46. PubMed ID: 15465201
[TBL] [Abstract][Full Text] [Related]
40. Nodular lymphocyte predominant Hodgkin's lymphoma.
Siddiqui N; Al-Diab AI
Saudi Med J; 2005 Feb; 26(2):241-5. PubMed ID: 15770298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]